For a stock that had been struggling for significance for much of the past year, this dramatic shift was not merely a rally — ...

We have an emerging new entrant in the increasingly crowded weight loss drug space.

Through the first three quarters of 2025, M&A activity overtook the entire 2024 total, according to Endpoints News. Editor and founder John Carroll wrote in October this might be the best time in 15 ...

He now feels Wave stock rates an outperform (buy, in other words), one full notch up from his previous sector perform (hold).

We came across a bullish thesis on Wave Life Sciences Ltd. on Valueinvestorsclub.com by zamperini. In this article, we will ...

Actively moving up the value chain toward drug discovery, development and digital therapeutics is key to sustaining the State ...

New York could lose research jobs, funding, and top scientific talent unless the state steps in as federal science funding grows more uncertain. That’s the warning from a broad coalition of more than ...

Life Sciences ventures face high levels of scientific, clinical and commercial pathway uncertainty, and these uncertainties present many opportunities for entrepreneurial innovation. This course is ...

Anavex Life Sciences' Phase 2B/3 trial failed to achieve statistical significance on both primary endpoints. Read why I ...

Join Bisnow’s Chicago Quantum & Life Science Forum - the only event bringing together researchers, entrepreneurs, investors ...

Understand the fundamentals that drive life. Do basic research that leads to medical breakthroughs and improvements in our world. Study the underlying chemistry of organisms and ecosystems. Help ...

The Board on Life Sciences (BLS) was established in 1984 to serve as the focal point for addressing critical, emerging policy and technical issues associated with the life sciences and biotechnology ...